FN London

Financial News

News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

Banks are among the biggest risers on UK’s green light for Oxford-AstraZeneca vaccine

Lenders bounce back after post-Christmas fall as new inoculation is approved

By

Penny Sukhraj

The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December
The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December Photo: Barry Lewis/Getty Images

Banking stocks were among the top climbers on the FTSE 100, which rose on 30 December on the back of the UK government’s approval of the Oxford-AstraZeneca coronavirus vaccine.

Pricing in the news of the vaccine saw an uptick across the banks including NatWest (+2.75%), Lloyds Banking Group (+2.24%), Standard Chartered (+2.03%), HSBC (+1.64%) and Barclays (+1.47%), along with financial services firms like Legal & General (1.81%).

WSJ Logo
GQG Launches Buyback After Stock Tumbles on Adani Probe

GQG Launches Buyback After Stock Tumbles on Adani Probe

Trump Considers Warsh Serving as Treasury Secretary—and Then Fed Chair

Large Accounting Firms Will Have to Submit Financial Statements to U.S. Regulator

Nvidia Is on Top but Does It Have Anywhere to Go but Down?

U.K. Consumers Cheerier Ahead of Holidays as Budget, U.S. Election Jitters Fade